On 23 March 2021, British Prime Minister Boris Johnson told a group of Conservative Party backbenchers: ‘The reason we have the vaccine success is because of capitalism, because of greed, my friends.’ Johnson was articulating the dogma that the pursuit of private profit through capitalist free markets leads to efficient outcomes. In reality, however, Britain’s accomplishments in developing the Oxford AstraZeneca vaccine and in the national vaccination rollout have more to do with state investments than the market mechanism. Government money subsidised the vaccine development at the University of Oxford, and it is the state-funded National Health Service that has carried out the vaccination programme. Johnson did not admit that it is due to capitalism and greed that Britain now has the fifth worst Covid-19 mortality rate in the world with over 126,500 deaths (almost 1,857 per million people in the population) and counting.
The
British government, like most neoliberal regimes, refused to take the measures
necessary to slow and halt community transmission, it failed early on to
provide health care and social care workers with adequate PPE and other
resources which could have saved the lives of hundreds of frontline staff who
died as a result. It contracted private businesses to carry out essential
activities, most with little or no relevant experience, for example, instead of
equipping the community-based GP system of the National Health Service to take
charge of ‘track and trace’, the government dished out £37 billion to Serco to
manage part of the system. In public health terms it has been disastrous; but
measured by Boris Johnson’s celebrated standards of capitalism and greed it is
has indeed excelled. The greatest beneficiaries of Britain’s response to the
pandemic have been the private corporations making huge profits. Around 2,500
Accenture, Deloitte and McKinsey consultants are on an average daily rate of
£1,000, with some paid £6,624 a day.
Johnson
has now laid out a road map for reopening the economy. As a result, even the
most optimistic scenario predicts a third wave between September 2021 and
January 2022 resulting in at least 30,000 additional deaths in Britain. These
deaths are preventable. But it precisely because the British government is
driven by the capitalism and greed that it insists that we have to learn to
‘live with the virus’ so that the business of business can continue.
Contrary
to Johnson’s claims, this pandemic has affirmed that public healthcare needs
cannot be adequately met under a profit-based system. Indeed, it is the absence
of the capitalist profit motive which underlies the outstanding domestic and
international response to Covid-19 by socialist Cuba, which now has five
vaccines in clinical trials and is set to be among the first nations to
vaccinate its entire population.
By
reacting quickly and decisively, by mobilising its public healthcare system and
world-leading biotech sector, Cuba has kept contagion and fatalities low. In
2020 Cuba confirmed a total of 12,225 coronavirus cases and 146 deaths in a
population of 11.2 million, among the lowest rates in the Western Hemisphere.
In November 2020, the airports were opened, leading to a surge with more
infections in January 2021 than the whole of the previous year. By 24 March 2021,
Cuba had registered fewer than 70,000 cases and 408 deaths. The death rate was
35 per million and the fatality rate was just 0.59% (2.2% worldwide; 2.9% in
Britain). Within one year, 57 brigades of medical specialists from Cuba’s Henry
Reeve International Contingent had treated 1.26 million Covid-19 patients in 40
countries; they joined 28,000 Cuban healthcare professionals already working in
66 countries. Cuba’s accomplishments are more extraordinary given that from
2017 onwards, the Trump administration punitively unleashed 240 new sanctions,
actions and measures to tighten the 60-year blockade of Cuba, including nearly
50 additional measures during the pandemic which cost the health sector alone
over $200 million.
Cuba
has gone on the offensive against Covid-19, mobilising the prevention-focussed,
community based public healthcare system to carry out daily house visits to
actively detect and treat cases and channelling the medical science sector to
adapt and produce new treatments for patients and Covid-19 specific vaccines.
These advances bring hope not just for Cuba, but for the world.
Some
200 Covid vaccines are being developed worldwide; by 25 March 2021, 23
candidates had advanced to phase III clinical trials. Two of those were Cuban
(Soberana 2 and Abdala). No other Latin American country has developed its own
vaccine at this stage. Cuba has three more vaccine candidates in earlier stage
trials (Soberana 1, Soberana Plus and an intranasal, needle-free vaccine called
Mambisa). How do we explain this accomplishment? Cuba’s biotech sector is
unique; entirely state-funded and owned, free from private interests, profits
are not sought domestically, and innovation is channelled to meet public health
needs. Dozens of research and development institutions collaborate, sharing
resources and knowledge, instead of competing, which facilitates a fast track
from research and innovation to trials and application. Cuba has the capacity
to produce 60-70% of the medicines it consumes domestically, an imperative due to
the US blockade and the cost of medicines in the international market. There is
also fluidity between universities, research centres, and the public health
system. These elements have proven vital in the development of Cuba’s Covid-19
vaccines.
As we know, there
are five types of Covid-19 vaccines being developed globally:
.
Viral vector vaccines, which inject an unrelated harmless virus modified to
deliver SARS-CoV-2 genetic material (Oxford AstraZeneca, Gamaleya and
SputnikV);
. Genetic vaccines containing a segment of SARS-CoV-2
virus genetic material (Pfizer, Moderna);
.
Inactivated vaccines containing disactivated SARS-CoV-2 virus
(Sinovac,/Butantan, SinoPharm, Bharat Biotec);
.
Attenuated vaccines containing weakened SARS-CoV-2 virus (Codagenix);
.
Protein vaccines containing proteins from the virus which trigger an immune
response (Novavax, Sanofi/GSK).
The
five Cuban vaccines under clinical trials are all protein vaccines; they carry
the portion of the virus spike protein which binds to human cells; it generates
neutralising antibodies to block the binding process. Dr Marlene Ramirez
Gonzalez explains that they are, ‘subunit vaccines, one of the most economical
approaches and the type for which Cuba has the greatest know-how and
infrastructure. From protein S – the antigen or part of the SARS-CoV2 virus
that all Covid vaccines target because it induces the strongest immune response
in humans – Cuban candidates are based only on the part that is involved in
contact with the cell’s receptor: the RBD (receptor-binding domain) which
is also the one that induces the greatest amount of neutralizing antibodies.
This strategy is not exclusive to Cuban vaccines. But Soberana 02 does
distinguish itself from the rest of the world’s candidates as the only
“conjugate vaccine”. Currently in phase III clinical trials, it combines RBD
with tetanus toxoid, which enhances the immune response…Cuba had already
developed another vaccine with this principle. It is Quimi-Hib, “the first of
its kind to be approved in Latin America and the second in the world”, against
Haemophilus influenzae type b, coccobacilli responsible for diseases such as
meningitis, pneumonia and epiglottitis.’
Idania
Caballero, a pharmaceutical scientist at BioCubaFarma points out that the
vaccines build on decades of medical science and work on infectious diseases.
‘The mortality rate in Cuba due to infectious diseases, even in times of Covid,
is less than 1%. Cuba today vaccinates against 13 diseases with 11 vaccines,
eight of which are produced in Cuba. Six diseases have been eliminated as a
result of vaccination schedules. The vaccines produced with these technologies
have been administered even to children in the first months of life.’
The Soberana vaccines are produced by the Finlay Institute in partnership
with the Centre for Molecular Immunology (CIM) and the Centre of Biopreparados.
Soberana means ‘sovereign’, reflecting its economic and political importance;
without a domestic product, Cuba would struggle to access foreign vaccines
either due to the US blockade or to the cost. Soberana vaccines insert genetic
information into superior mammalian cells. Soberana Plus is a the world’s first
vaccine for Covid-19 convalescent patients to reach clinical trials.
The other vaccines, Abdala and Mambisa, names which also pay tribute to
Cuba’s struggle for independence, are produced by the Centre of Genetic
Engineering and Biotechnology (CIGB). These vaccines insert genetic information
in a less evolved organism, a unicellular microorganism (the yeast Pichia
Pastoris). They build on the CIGB’s extraordinary record, including its
Hepatitis B vaccines, used in Cuba for 25 years.
By
developing different vaccine platforms, those institutions avoid competing for
resources. Caballero explains that: ‘Cuba has the capacity to produce two
independent vaccine chains, with over 90 million vaccines annually, while
maintaining the required production of other products for the domestic market
and for export.’ The Cuban vaccines require three doses and, because they are
stable at temperatures of between 2 and 8 degrees, do not require costly
special refrigeration equipment.
By late March, phase III trials were underway for
Soberana 2 and Abdala, each incorporating over 44,000 volunteers over 19 years
old in regions with high incidence of Covid-19. Soberana 2 is being
administered in Havana and Abdala in Santiago de Cuba and Guantanamo. Analysis and
follow-up for phase III trial patients will continue until January 2022 to
investigate whether they prevent transmission, how long immunity lasts, and
other questions that no vaccine producers can yet answer. However, an
additional 150,000 healthcare workers in Havana are receiving Soberana 2 shots,
as part of an ‘interventional study’, a form of clinical trial that can be
authorised after drug safety has been demonstrated in phase II. Intervention
studies do not involve double blind testing or placebos. Another 120,000
healthcare workers in western Cuba will receive Abdala in the next few weeks.
Other interventional studies in the capital will see 1.7 million people in
Havana, most of the adult population, vaccinated by the end of May 2021,
meaning that 2 million Cubans will have been fully vaccinated.
Assuming
satisfactory results, in June the real national vaccination campaign will
begin, prioritising groups according to risk factors and starting with over
60-year-olds. By the end of August 2021, six million Cubans, over half the
population, will have been covered and by the end of the year, Cuba will be
among the world’s first countries to fully vaccinate its entire population.
Cuban
medical scientists are confident that they have the capacity and experience to
adapt their vaccine formulations, technologies and action protocols to tackle
new variants. The next steps are for
Soberana 1 and Soberana Plus to enter phase II trials and a new study involving
5 to 18 year olds will be launched.
Cuba’s
CIGB have teamed up with colleagues in China to work on a new vaccine called
Pan-Corona, designed to be effective on different strains of the coronavirus.
It will use parts of the virus that are conserved, not exposed to variation, to
generate antibodies, combined with parts directed at cellular responses. The
Cubans contribute the experience and personnel, while the Chinese provide
equipment and resources. The research will take place at the Yongzhou Joint
Biotechnology Innovation Center, in China’s Hunan Province, which was
established last year with equipment and laboratories designed by Cuban
specialists. Gerardo Guillen, director of biomedical science at CIGB said the
approach: ‘could protect against epidemiological emergencies of new strains of
coronavirus that may exist in the future’. The project builds on nearly two
decades of medical science collaboration between Cuba and China, including five
joint ventures in the biotech sector.
Cuban
professionals have received ten gold medals from the World Intellectual
Property Organisation (WIPO) over 26 years; their biotech products were
exported to 49 countries prior to the pandemic, including vaccines used in
childhood immunisation programmes in Latin America. Cuba has stated that its
Covid-19 vaccines will be exported to other countries. This brings hope to low-
and middle-income nations that simply cannot afford to vaccinate their
populations at high prices (between $10 and $30 per dose) demanded
by big pharma. In February 2021, the Bureau of Investigative Journalism
reported that US company Pfizer has been ‘bullying’ Latin American countries
into putting up sovereign assets, such as embassy buildings and military bases,
as guarantees against the cost of any future legal cases in relation to their
Covid-19 vaccines.
Through
an agreement with Iran’s Pasteur Institute, 100,000 Iranians will take part in
the phase III clinical trials for Soberana 2 and another 60,000 people will
participate in Venezuela. Other countries including Mexico, Jamaica, Vietnam,
Pakistan, and India, have stated their interest in receiving the Cuban
vaccines, as has the African Union, which represents all 55 nations in Africa.
It is likely that Cuba will apply a sliding scale to its Covid-19 vaccine
exports, as it does with the export of medical professionals, so what it
charges reflects the countries’ ability to pay.
What
Cuba has achieved is remarkable, but as Caballero states: ‘without the unjust
US blockade, Cuba could have more and better results’. Cuba has become a
world-leader in biotechnology because it has a socialist state with a centrally
planned economy, that has invested in science and technology and puts human
welfare before profit; that is, with the absence of capitalism and greed that
British Prime Minister Johnson celebrates.
On
the anniversary of the United Kingdom’s first lockdown of the coronavirus
pandemic, as candles were lit in doorways and the country mourned 125,000
deaths, as I mentioned above, the prime minister was in the mood for gloating.
“The
reason we have the vaccine success is because of capitalism, because of greed
my friends,” Boris Johnson reportedly told Conservative MPs, before pleading
“forget I said that”.
The
timing of the comments was distasteful in the extreme as countries across the
world are struggling to find any vaccines, while Britain has acquired several
times the doses it needs by bypassing the international bodies meant to ensure
a fair global allocation. But more worrying was the warped understanding
revealed by the remark of what is actually behind Britain’s successful vaccine
rollout.
Johnson
claimed the vaccine breakthrough was brought about by “giant corporations that
wanted to give good returns to shareholders”. But nothing could be further from
the truth. The British government, like other governments, invested heavy
public funds into the research and development of vaccines, assuming most of
the risk in the process.
The
AstraZeneca jab was actually developed by scientists from the University of
Oxford, a publicly-funded institution, working with scientists from a range of
backgrounds, including many educated in state schools. Those scientists had
initially wanted to make their vaccine patent-free, before AstraZeneca entered
the scene, effectively privatising the research.
The
vaccines have been brought to market thanks to tens of thousands of trial
volunteers who risked their health by putting themselves forward, not out of
greed, but out of a desire to end this pandemic and help their families and
communities. And the rollout is being managed by the UK’s National Health
Service (NHS), a world-class public healthcare system that, despite
market-driven reforms in recent years, exists entirely outside the logic of the
market.
Greed,
however, drove Big Pharma companies to privatise vaccines developed with public
resources, and patent lifesaving medicines, in an effort to keep a grip on their
monopolies. As a result, pharmaceutical giants sold these jabs almost
exclusively to rich countries, allowing the UK to secure enough doses to
vaccinate its population three times over.
Even
the European Union is struggling to secure doses, and is now engaged in a
bitter war of words with Britain. This is because Johnson’s “me-first”
approach, combined with the secret contracts which are a consistent feature of
Big Pharma-owned drugs, has fuelled anger and suspicion. Much worse, many low-
and middle-income countries will have to wait until at least 2023 to vaccinate
a large enough percentage of their populations to achieve herd immunity.
And
what has stopped the global south countries from making their own vaccines, and
instead forced them to wait for the pharmaceutical giants to decide it is their
turn? Greed again. The UK, US, and the EU – home to the world’s largest
pharmaceutical companies – have blocked attempts led by India and South Africa
to temporarily waive patents on COVID-19 vaccines. A waiver would, they
claimed, hurt “incentives” – or profits, in plain English.
All
this is a perfect example of Johnson’s economic strategy – transferring massive
public resources into the hands of large corporations and then tasking them
with carrying out vitally important services for the public. Increasingly these
contracts seem to be awarded on the basis of closeness to the Conservative
Party. Transparency is an afterthought at best, and while these companies do
indeed seem to excel at transferring value to their shareholders, they are much
less competent at delivering public services. The multibillion-pound disaster
that is Britain’s test and trace system is just one leading example of this.
When
it comes to vaccines, the consequences of this strategy are clear for all to
see. If all of the vaccines due to be delivered in 2021 were distributed
equitably, we could vaccinate 70 percent of the world this year, effectively
ending the pandemic. Greed is preventing it. The incompetence of AstraZeneca’s
rollout is now helping fuel vaccine scepticism across the world. And the
secrecy of its contracts is fostering a dangerous vaccine war between the EU
and the UK.
AstraZeneca
is not the only greedy company in the vaccine race. Many other corporations
have also happily taken public resources, sold virtually their entire stock to
rich countries, and are now looking forward to securing sky-high profit
margins. Pfizer is on target to make more than $4bn clear profit this year, and
Moderna’s executives are raking in hundreds of millions of dollars based on the
company’s rocketing share price.
Johnson
is rapidly emerging as the most vocal proponent of this form of capitalism – an
economic model characterised by monopoly power, cronyism and the transfer of
huge resources from the public sector, the environment, and working people into
the private wealth of the global elite.
The
immediate consequence of this is the prolonging of the pandemic, as coronavirus
is allowed to run rampant in poorer countries, taking countless lives that could
have been saved. But the longer-term consequences will be even more
catastrophic: unprecedented levels of inequality, runaway climate change and
the erosion of trust in democratic institutions.
Greed
is not what has led to the UK’s successful vaccine rollout. Instead, it risks
derailing efforts to end this crisis. Those of us who want to make sure the
world is not only safe from COVID-19, but from the crises of poverty,
inequality and climate change, rather than celebrating greed, need to work out
how to restrain it as quickly as possible.
PALESTINA
The fall of Jerusalem to the First Crusade in 1099
stunned the world of Islam, which was at the peak of its achievements. Damascus,
Cairo and Baghdad were large cities with combined population of over two
million—advanced urban civilisation at a time when the citizens of London and
Paris numbered less than fifty thousand in each case. The Caliph in Baghdad
was shaken by the ease with which the barbarian tide had overwhelmed the
armies of Islam. It
was to be a long occupation. – Tariq Ali, The Book of Saladin
Applied Empathy (i.e., caring) regarding events in the
Middle East has taken a beating over the decades. Fatigue has set in and we
don’t really care anymore — an indifference has been exposed that is up there
with Climate Change for imminent demise. Maybe they are linked. Maybe the real
pandemic underway is mental. Some kind of fight-flight-freeze intuiting of
catastrophic danger ahead for us all as we hurdle toward the Singularity.
This fatigue point has been reached incrementally over
the years since the end of WWII, which ended with the Big Bang of our
unnecessarily nuking the Japs to spite the Russkies. “Now I am become Death,
the destroyer of worlds,” Robert Oppenheimer quietly noted.Gods of Death, as
Freud, and others, figured we’d end up as. After WWI, newly discovered Middle
East oil became the most prevalent source of world energy, leading to
“skirmishes” for its wealth, after the breakdown of the Ottoman Empire. And the
other major transformative event for the region was the Jewish demand, after
WWII and the Holocaust, for a homeland — based upon historical precedence.
The world has been delighted to watch the wilderness
religions — Christians, Islam and Judaism — duke it out for millennia, like
three irascible siblings each intent on domination. The Three Abes (they all
derive from Abraham) have, individually or together, shaped the way the world
has progressed economically, spiritually, militarily, and morally for at least
1000 years, going back to the Crusades. So, though we are fatigued with the
whole lot of them, the Three Abes still hold our attention, and what happens in
the Middle East today still has far-reaching consequences for our collective
future. Arab oil, especially plastics and carbon emissions, has filthified the
world, maybe beyond rescue. Tensions between Israel and its neighbors,
especially Iran and Syria, threaten to act as a catalyst for apocalyptic destruction.
In this still developing regional denouement with global consequences, the
human rights violations in Palestine / Israel, that we hear about almost every
day, just don’t move us; we no longer expect much to change.
The Book of Ramallah, a collection of 10 short stories from the West Bank
city, attempts to stir our interest again. The book, part of the Comma Press
(UK) ‘Reading the City’ series, focuses on human stories that emphasize people
and their environs over a strictly political posturing. Part of the deadening
of our response to the so-called Israeli-Palestinian Question, over the
years, has been the MSM filtering of events there as “political” rather than human.
Always we talk about the “two-state solution,” even when there is no hope of
that now. We don’t talk about America’s role in the demise of that “Solution.”
But what is Ramallah? I pictured a dust town of cinder
block barrios, because destruction and cheap construction seem to be the only
images we are provided by the MSM in the telling of the region’s story. But
it’s a modest modern city worth getting a true picture about before reading the
stories. A quick glimpse is provided by LivingBobby at YouTube.
Palestinians are not dust monkeys, as is suggested by some MSM accounts, but
vibrant and as materialistic as the rest of us. They’ve tasted of the sugar,
and want more. Israel says to them, you can have more sugar, but first…. kow-tow.
But, as Maya Abu Al-Hayat, reminds us in the
introduction to The Book of Ramallah, ancient frictions act as a frisson
to affairs there:A place of tension as well as excitement, with its many tower
blocks and mosques, churches and bars, and where gunfire can always be heard in
the distance, resounding to a backdrop of curfews, arrests, sieges, strikes and
martyrs.
It’s a quiet book, but there’s tomfoolery going on in
the background that brings disquiet.
The first thing that struck me about the stories is
their relative narrative simplicity; there are few lyrical flourishes to amaze,
although there are certainly plenty of spirited flashes of imagination, inclusions
on the whole are stoical — we are dealing with ordinary people, with limited
material wealth and dealing with the everyday stress of the Israeli occupation
of their homeland, and this subjugation comes across in their often subdued
utterances.
In the opening story, “Love in Ramallah,” a bus and
several cars are held at the Uyoun al-Haramiya checkpoint, and the passengers
are forced to get out of their vehicles. While they wait for the slow and
deliberate wheels of bureaucracy to move them through, an Israel Defense Force
(IDF) soldier decides to have some sadistic fun. He tells the passengers that
nobody gets through the checkpoint until a young Palestinian boy kisses a young
girl, a violation of cultural norms:In front of the checkpoint, the soldiers
were giggling to themselves. Rummaging for change in their pockets and passing
it around, they began placing bets on whether he would kiss her or not.
Amusement and humiliation. Fascist delight and
schadenfreude. All that’s missing is a bitter lemonade stand.
When Na’eem, the boy, refuses, the IDF soldier beats
him — the rifle butt struck his thigh. Everyone heard the thud on his femur
before he fell to the ground, only for the soldier’s jackboot to follow up….
To prevent further bloodshed, the young runs to the
boy and tells him to kiss her; he does, and the ordeal is almost over. They are
free now to cross the checkpoint, but on the bus, the passengers’ eyes
reflected a mixture of shame, oppression, anger and disapproval. They stared
brokenly at the floor; silence was the new passenger they had taken on.
This simple, editorially well-placed story sets the tone
for the reader’s expectations. And when the authors depict a lifestyle of
multiple checkpoints per day.
In the ironically titled, “A Tragic Ending,” Mahmoud
Shukair titillates the reader with the tale of Hatem, a man in search of women.
A kind of subplot sees his friend Muawiya, a local wannabe politician who goes
around “loudly pontificating about ‘the nation’ and ‘the people’ so everyone
could hear.” Dramatic tension is built in his suspicion that he’s being tailed
by an “informant,” a possibility he might find useful as he runs for local
office. We get pictures of Hatem’s hirsute neighbor girl who frequently comes
on to him, lifting her dress to reveal her hairy legs. “He had never taken a
liking to her, even though she was so kind-hearted that it verged on
stupidity.”
Instead, he longs for Randa, who he has peeped on
without drawing her attention, and realizes his love for her will be unrequited
when she moves to America after marrying her cousin. Aziza is a married woman
with a surplus of sensual commodities with whom Hatem carries on an affair,
until she is almost caught red-honeyed by her husband; Hatem climbs out a
window and hears screams of torture coming from the honey pot. He moves to the
city. He ends up with the hairy woman. Shukair’s tale is a clever and comical
suggestion of the idleness (and boredom) of men in Ramallah — they’re either
getting laid or running for office. (In America, it often amounts to the same
thing.) Shukair seems uninterested in promoting any seriousness regarding
politics — Palestinians have no power, and Muawiya is no resistance fighter.
But the subtle humor suggests Boccaccio or 1001 Nights.
But there is no humor in the Occupation of the West
Bank and the ‘lifestyle’ it imposes on Palestinians. The swisscheesification of
the West Bank has led to communities separated by private Israel roads with
checkpoints everywhere, a situation making a two-state solution almost impossible.
The Oslo Accords, on paper, provided more autonomy and self-rule to
Palestinians, such ‘progress’ is subverted by the infrastructure that connects
Israeli settlements. As Al-Hayat notes in the introduction, (Although Ramallah
was designated an ‘Area A’, in the Oslo II Accord, meaning it had full civil
and security control, and was out of bounds for Israelis, the Israel Defence
Forces (IDF) still dominate the network of roads surrounding it, many of which
are bypasses that only Israeli citizens can use, servicing the many
expropriated land settlements that have sprung up throughout the West Bank in
the years since Oslo).
It is hard to grasp the accommodation required to make
this situation palatable or even practical from the point-of-view of centralized
governance.
The absurdity of this situation is brought out
wonderfully in “At the Qalandiya Checkpoint,” by Ameer Hamad. The reader is
introduced to an irascible narrator who was born at a checkpoint, his father
running in his underwear from Jerusalem to Nablus to get there for the birth.
The father nicknames his son Salah al-Din, after the legendary anti-Crusader
who defended the Holy Land from invaders. Salah al-Din grumbles and grouses
about all the time he and others have spent at checkpoints. He tells us about
checkpoints in other countries, their relative humanity: There they will try to
force you to read, study, listen to music or do yoga for hours on end; someone
has even opened a pop-up café called ‘Love at the Checkpoint’.
But for al-Din and his compatriots, anthropologists
reckon they’ve lost years waiting at checkpoints.
Hamad reflects on time, one of the things people do
while waiting, and trots in Samuel Beckett for a cameo tap dance about time: To
be fair, this checkpoint has its advantages, most notably the fact that waiting
here makes you experience time in its purest form. As Samuel Beckett famously
observed, it doesn’t get purer than this. Indeed, to quote Ronan McDonald in
his Cambridge Introduction, Chapter 3, page 67, second sentence: ‘Beckett wrote
Waiting for Godot in the hours he spent at the Qalandiya checkpoint between 1948
and 1949 while he was teaching Absurdist Literature at Birzeit University.’
The Palestinians, too, are waiting absurdly for their
Homeland to arrive and pass time aimlessly. For Salah al-Din days at the
checkpoints have become theatre, full of dramatic tensions. He let’s a woman
cut in line, only to see that line close a minute later. He observes
“jetsetters” given priority processing.
Al-Din enters into a revealing dialogue with a
checkpoint guard, a Russian Jew emigre, who takes a liking to al-Din’s wit, but
who is an unshakeable bureaucrat. Al-Din refuses to tell the guard about his
past but is invited to project the future: ‘I am the one who will free Jerusalem,
and bring the sun back to Haifa. I’m the one who will demolish this whole damn
checkpoint and bulldoze it over your grandfathers’ graves. I’m the one who will
single-handedly bring back all the refugees, and deliver self-determination to
the entire Arab world, I’m the one –’‘But you’re Kurdish. Why are you bothered
about the Arabs?’
‘And you’re Russian. What do you care about
Palestine?’
Pasts and futures merge into a frictional present. But
mostly diaspora Jews come from everywhere to settle in the Promised Land — at
the Palestinians’ expense.
Americans aren’t all that keyed-in or motivated to
“help” the Palestinans fight the Israelis in courts and at the United Nations
to secure their native homeland. People seem to have forgotten that the area of
occupation — the whole region now known as Israel — was once, not long ago, on
the map as Palestine. As mentioned earlier, settlers to West Bank have ruined
Palestinian society and self-governance with their settlements, which
expropriate Palestinian lands by armed and often-fanatical Zionists, who divide
the West Bank with private roads. According to a 2015 Newsweek piece, Americans
Jews are “over-represented” as settlers and, since the Oslo
Accords in 1993, have helped grow the settler population from 110, 00 to 400,
000 and “helping make the two-state solution impossible.” “Why are so many US citizens moving to the West
Bank?”
is a recent and brief interview with settlers worth watching for its
exploration of motivations.
What’s left out of those interviews is the hypocrisy
and unmitigated evil some of these settlers bring with them to the West Bank.
These Americans could not do, and would probably fight to make sure it never
happened, what they do in the West Bank — bulldozing homes, creating barriers,
and jigsaw private roads that cut off Palestinians from each other and require
hours spent at checkpoints. A lot of these settlers go to Israel because the
land is cheap, they are welcome, and it’s beautiful where they are going. But
they are helping participate in an Apartheid system to obtain and sustain a
contradictory lifestyle. This seems to be a facet of ugly Americanism that is
common throughout the world — American middle class expats going to other
countries, living often rent-free, and lording over the locals, enjoying the
privilege of hiring the locals as servants for paltry wages, etc.
There’s been resistance to such treatment over the
years. Plenty of American Jews are vocal in their opposition to settlers
participating in a system that smells of hypocrisy and apartheid. Palestinian
resistance to the Occupation began in earnest with Yassir Arafat, the first
president of the Palestinian National Authority, and co-winner of the 1994
Nobel Peace Prize. Arafat, for all his alleged faults, undeniably pushed for
autonomy and self-rule — a struggle that continues, but without effective or
visionary leadership. He called for the First Intifada (‘uprising’) in December
1987, following an incident at the Erez checkpoint during which four
Palestinians were accidentally killed by an Israeli and set off an emotional
firestorm. It lasted until 1993. The Second Intifada (known as Al-Aqsa) went
from 2000-2005.
From Carl Jung to Margaret Mead, we ‘ve learned as
humans over time that we will seek answers to continuous horrible events by
collectively believing in supernatural forces, which often coalesce around atavistic
figures imbued with special mysterious powers to be feared. “Badia’s Magic Water”
by Maya Abu al-Hayat is a story of sympathetic magic — word gone out — rumors
that — there’s talk — people are saying that this woman Badia has a magic
potion that heals. Born of a dead baby lost during the First Intifada, after
which she developed eczema, Badia’s herbal potion cures it, and as she takes a
job washing the dead, providing their last ablutions and shrouding, she gains a
rep as a healer.
Folks come from all around
Ramallah to get some of Badia’s holy water. Sometimes they go to extremes, Badia
recalls, with regret: the woman who once snuck into the autopsy room to steal
some of the magic water that had spilled off a girl’s corpse, to use it for
some spell or ritual, who, when Badia tried to remove her, had bent down to
where the water pooled on the ground and tried to lick it up.
You can’t help but interpret such extreme behavior as
a failure of modernity to take hold in a culture beset by the mindset of ancient
and tyrannical bugaboos. There’s a biblical apocrypha feel to it. It seems like
it will take a miracle to save the Palestinians. But, at the same time, though
Badia can’t help “those that don’t believe,” she is self-amused at her power.
Al-Hayat expresses it with simplicity: No dead today: the schedule is blank.
Badia sighs, removes her coat, puts on her clean white gown, and drinks the
special tea of herbs she brewed herself.
Superstitions, right? They are even behind the
Occupation, when you think about it.
The Book of Ramallah is a simple, concrete
collection of tales that reveals some of the ‘tender mercies’ and
often-humorous day-to-day travails of Palestinas going about their business
under Israeli occupation. The tales humanize and almost laugh at political
solutions to anything. In doing so, they help us re-realize, paradoxically,
that a political solution is a decision of people, not autonomous systems of
power. It’s a gentle, non-confronting set of stories that bring refreshing
energy to the ongoing crisis for Palestinians in the West Bank and elsewhere in
their diaspora.
Readers who want a deeper, more engaging (but
entertaining) understanding of how the region fell so miserably into conflict
between the Palestinians, largely displaced from their homeland, and Israelis
who see their state as a historical and spiritual manifest destiny, may want to
watch the 4-part BBC series The Promise (2011), which recounts the
events that led to the turmoil, beginning with the fall of the Ottoman Empire,
the realignment of Arabia by the British, the promise made to Jews in The Balfour Declaration, and the Never Again militancy
brought to Jewish emigration to the region by the Holocaust.
There is one unique problem with « The Promise ».
It brings you back to the Second Intifada without mentioning that the
Palestinians stopped their attacks on Israel in 2005 and replace dit by the pacific
BDS Movement of Boycott, whereas Israel never stoppe dits terrorist attacks on Palestinian
Occupied Territories.
Palestinian
Center for Human Rights
International
Solidarity Movement – Nonviolence. Justice. Freedom
Defense for Children
Breaking the Silence
AOS FATOS: As
declarações de Bolsonaro, checadas
Nenhum comentário:
Postar um comentário